PIK3CA and cancer: A subset of PIK3CA-mutant cancers harbor multiple copies of mutant PIK3CA in cis (same allele) or trans (separate alleles) that additively affect downstream signaling and cellular phenotypes in a dose-dependent manner [35–37] or elicit biphasic effects [35–38].